There is an age-old debate about whether blood pressure medications cause depression. This study is one of the largest to tackle the issue, and it suggests this risk may be limited to one class of antihypertensives in particular.
Read More
A seven-hour series about chess tournaments doesn’t sound like a blockbuster, but The Queen’s Gambit is currently the #1 show on Netflix. The show makes a bold opening move by casting a woman in the role of the young champion—an unlikely choice, but one that stands on strong empiric ground.
Read More
Lamotrigine is approved for the prevention of bipolar episodes, but Dr. Aiken explains why it may also treat active bipolar depression. This mood stabilizer is among the most tolerable in its class, and has additional benefits in OCD, borderline personality disorder, and depersonalization disorder.
Read More
The gut microbiome is one of the newest entries in the list of causes of depression. Ted Dinan explains how the bacteria in the GI tract influence the brain, and whether a probiotic or a lifestyle change is the best way to address it.
Read More
Dr. Aiken is the Editor in Chief of The Carlat Psychiatry Report; director of the Mood Treatment Center in North Carolina, where he maintains a private practice combining medication and therapy along with evidence-based complementary and alternative treatments; and Assistant Professor NYU Langone Department of Psychiatry. He has worked as a research assistant at the NIMH and a sub-investigator on clinical trials, and conducts research on a shoestring budget out of his private practice. Follow him on Twitter and find him on LinkedIn.
_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.jpg?1729528747 "KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg")
